Drug intelligence / Profile preview

cholesterol + DEKAS Plus

Development stage
Unknown
Lead developer
Callion Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

A therapeutic regimen consisting of dietary cholesterol supplementation and the antioxidant formulation DEKAS Plus, currently under investigation in Phase 2 clinical trials by the University of Colorado, Denver. This combination therapy is designed to treat Smith-Lemli-Opitz Syndrome (SLOS), a genetic disorder characterized by a deficiency in the enzyme 7-dehydrocholesterol reductase (DHCR7). By providing exogenous cholesterol, the treatment aims to normalize plasma cholesterol levels and suppress the endogenous synthesis of 7-dehydrocholesterol (7-DHC). The addition of DEKAS Plus, which contains vitamin E and other antioxidants, is intended to mitigate the formation of neurotoxic oxysterols derived from the accumulation of 7-DHC and 8-DHC, thereby potentially improving retinal function and hearing in affected patients.

Other names
Cholesterol and Antioxidant TreatmentCholesterol supplementation and antioxidant therapy

Beyond the preview

Go deeper on cholesterol + DEKAS Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cholesterol + DEKAS Plus.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call